JENIVISION INC has a total of 24 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2015. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are BIONOOX SUISSE SA, HYPERMARCAS S A and EDKO PAZARLAMA TANITIM TICARET LTD SIRKETI.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | China | 3 | |
#4 | Republic of Korea | 3 | |
#5 | Australia | 2 | |
#6 | Canada | 2 | |
#7 | EPO (European Patent Office) | 2 | |
#8 | Mexico | 2 | |
#9 | United Kingdom | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Specific use of cosmetics |
# | Name | Total Patents |
---|---|---|
#1 | Wang Weizhen | 21 |
#2 | Woodward David Frederick | 9 |
#3 | Woodward David | 7 |
#4 | Woodward David F | 5 |
#5 | Weizhen Wang | 3 |
#6 | David Woodward | 1 |
#7 | David Frederick Woodward | 1 |
#8 | David F Woodward | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020251926A1 | Methods and formulations for treating vision disorders | |
CN110996964A | Preparation for hair growth | |
US2017209418A1 | Use of prostacyclin antagonists for treating ocular surface nociception | |
US2017049734A1 | Quantitative peri-orbital application of ophthalmology drugs |